Biocon surges as its arm gets USFDA’s nod for Dapagliflozin Tablets

[ad_1] Mumbai, April 8 (Udaipur Kiran): Biocon is currently trading at Rs. 345.50, up by 5.35 points or 1.57% from its previous closing of Rs. 340.15 on the BSE. The scrip opened at Rs. 349.10 and has touched a high and low of Rs. 351.45 and Rs. 344.30 respectively. So far 1126885 shares were traded […]

Read More

Zydus Lifesciences gains on getting USFDA’s approval for ‘Dapagliflozin Tablets’

[ad_1] Mumbai, April 8 (Udaipur Kiran): Zydus Lifesciences is currently trading at Rs. 884.35, up by 10.70 points or 1.22% from its previous closing of Rs. 873.65 on the BSE. The scrip opened at Rs. 910.80 and has touched a high and low of Rs. 910.80 and Rs. 879.90 respectively. So far 29876 shares were […]

Read More